Tumorp16M is a possible marker of advanced stage in non-small cell lung cancer
- 17 January 2002
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 79 (2), 101-106
- https://doi.org/10.1002/jso.10046
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lungBritish Journal of Cancer, 2000
- DNA methylation and expression ofp16INK4A gene in pulmonary adenocarcinoma and anthracosis in background lungInternational Journal of Cancer, 1999
- Independent prognostic role of p16 expression in lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancersBritish Journal of Cancer, 1999
- Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosisProceedings of the National Academy of Sciences of the United States of America, 1998
- Correlation between methylation status of thep16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancersInternational Journal of Cancer, 1998
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Intragenic mutations of the
p16
INK4
, p15
INK4B
and p18 genes in primary non‐small‐cell lung cancersInternational Journal of Cancer, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995